Jon E. Grant to Catechol O-Methyltransferase Inhibitors
This is a "connection" page, showing publications Jon E. Grant has written about Catechol O-Methyltransferase Inhibitors.
Connection Strength
0.658
-
Kleptomania treated with tolcapone, a catechol-O-methyl-transferase (COMT) inhibitor. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15; 35(1):295-6.
Score: 0.372
-
A systematic review of the cognitive effects of the COMT inhibitor, tolcapone, in adult humans. CNS Spectr. 2024 Jun; 29(3):166-175.
Score: 0.235
-
Cortical dopamine reduces the impact of motivational biases governing automated behaviour. Neuropsychopharmacology. 2022 07; 47(8):1503-1512.
Score: 0.051